68 results
8-K
EX-99.1
NVRO
Nevro Corp
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am
of the Nevro team to serve our customers and patients, and execute on our plans throughout a difficult environment in 2021,” said D. Keith Grossman
8-K
EX-99.1
NVRO
Nevro Corp
1 Apr 20
Nevro Provides First Quarter and FY2020 Update
4:21pm
to be at or below approximately $90 million.
Full Year 2020 Financial Guidance
Due to the rapidly evolving environment and continued uncertainties resulting from
8-K
EX-99.1
NVRO
Nevro Corp
5 Aug 20
Nevro Announces Second Quarter 2020 Financial Results
4:19pm
remain cautious about the visibility and predictability of our environment through the end of 2020. We are monitoring new pandemic developments closely
8-K
EX-99.1
NVRO
Nevro Corp
5 May 20
Nevro Reports First Quarter 2020 Financial Results
4:16pm
to support high frequency SCS therapy.
2020 Financial Guidance
Due to the rapidly evolving environment and continued uncertainties resulting from
8-K
EX-99.1
3e28993v xapwrfhk
4 Aug 21
Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance
4:20pm
8-K
EX-99.1
250s4hdnye
24 Feb 21
Nevro Reports Fourth Quarter and Full Year 2020 Financial Results
4:26pm
8-K
EX-99.1
1mksqnyq vx
5 May 21
Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance
4:16pm
8-K
EX-1.2
a27uw0 9g
7 Apr 20
Entry into a Material Definitive Agreement
7:00am
8-K
EX-1.1
7p179gpmwymv
7 Apr 20
Entry into a Material Definitive Agreement
7:00am
10-K
EX-10.23
ezbj7bs 1vgt8
18 Mar 15
Annual report
12:00am